Search Results

You searched for : Mylan  

Success story of Aurobindo Pharma

In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system ...
Sep 21

Top pharma stocks for long term investing : The companies to watch for in next 5 years

The pharma stocks for long term wealth creation ...
Jan 11

Top Ten Mid Cap Indian Pharma Stocks ; January 2021

Top ten mid cap Indian pharma stocks , January 2021...
Jan 07

Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart

Biocon subsidiary Mylan advances their ...
Dec 14

Technology - an integral part of medicine says Dr. Shubham Painoli, Quality Manager – Clinical Operations, DayToDay Health

...
Dec 09

Lupin receives approval from USFDA for Penicillamine Tablets USP

Penicillamine Tablets USP, 250 mg, are indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis...
Dec 01

Mylan collaborates with CSIR for management of COVID-19

A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration...
Sep 23

Preparation products of Yiling Pharma approved by FDA for launch in the US market

Receives ANDA for Lisinopril and Acylovir tablets...
Sep 21

US warns Pharma firm Mylan over quality

The Food and Drug Administration recommended Mylan Chief Executive Officer Heather Bresch hire a consultant to help the generic drugmaker improve its manufacturing practices...
Sep 03

Biocon Biologics and Mylan announce launch of Semglee in the U.S.

Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ...
Aug 31

Lupin and Mylan launch Nepexto, biosimilar etanercept in Germany

The approval of Nepexto by the European Medicines Agency (EMA) underlines the scientific success of Lupin’s biosimilar programs...
Aug 26

3 Indian companies start supply of life-saving Remdesivir

Nepal's Medical Council's directive (Interim Clinical Guidance for COVID-19) also has enlisted Remdesivir drug for the primary medication....
Aug 22

New treatment for highly drug-resistant tuberculosis

TB Alliance announces European commission authorisation of new treatment for highly drug-resistant tuberculosis ...
Aug 04

Mylan Secures Regulatory Approval for Remdesivir in India

Mylan will manufacture remdesivir in India and would sell at Rs4,800 which is 80% less than the price in developed countries...
Jul 10

Cipla set to undercut rivals with generic remdesivir

Cipla had earlier said pricing would not exceed 5,000 rupees. On Tuesday, Sovereign Pharma, which is manufacturing and packaging the drug for Cipla...
Jul 09

HM allows of HCQ in early stages of Coronavirus ; Remdesivir for moderate cases

Health Ministry drops Azithromycin, suggest HCQ and Remdesivir instead for COVID patients...
Jun 15

Biocon and Mylan Announce U.S. FDA Approval of Semglee

Semglee is to be offered in vial and pen presentations...
Jun 12

Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for Lantus SoloSTAR

Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable....
Jun 02

Biocon Biologics receives EU GMP certification

Biocon Biologics receives EU GMP certification for multiple biosimilars manufacturing facilities in Bengaluru ...
May 27

Gilead Sciences collaborates with Indian Companies for Remdesivir

Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ...
May 13

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept

The CHMP positive opinion will now be considered by the European Commission (EC). Once approved the EC will grant a centralized marketing authorization for member ...
Mar 28

Biocon and Mylan Win Patent Litigation Cases Against Sanofi

CEO of BIOCON confirmed "We are extremely pleased with the U.S. court ruling in favour of our Insulin Glargine device as this takes us ...
Mar 12

U.S. FDA Accepts Biologics License Application for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review

Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U....
Mar 12

Biocon attracts Rs 536.25 crore from True North for a 2.44% minority stake

True North to invest 536.24 crores in Biocon for 2.44% minority stake...
Jan 07

China Relaxes Import Regulations to Improve Access and Availability of Affordable Medicines

...
Sep 13

25 Matching result(s) found!